Vixen Pharmaceuticals Private Limited
About Vixen Pharmaceuticals Private Limited
Data last updated:
Vixen Pharmaceuticals Private Limited is a private limited company based in Kaithal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999HR2017PTC070308.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Naveen and Ravi.
Its last annual general meeting (AGM) was held on 12 August 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at H.No – 163/13 Friends Colony, Kaithal, Haryana, India – 136027.
As per the financials filed for FY 2020, the company reported a revenue of ₹7.13 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹18,545 (net margin -2.6%) and EBITDA of -₹6,492 (EBITDA margin -0.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vixen Pharmaceuticals Private Limited's registered office is in Kaithal, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No – 163/13 Friends Colony, Kaithal, Haryana, India – 136027
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vixen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vixen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vixen Pharmaceuticals Private Limited, buy the company report.
Financials of Vixen Pharmaceuticals Private Limited
FY 2020 filings availableVixen Pharmaceuticals Private Limited reported revenue of ₹7.13 Lakh (up 32% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 32% in the latest year. EBITDA rose 87% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹7.13 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹6,492 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹18,545 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -0.9% | ||
| Net Profit Margin | -2.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Vixen Pharmaceuticals Private Limited, buy the company report.
Auditor
Vixen Pharmaceuticals Private Limited is audited by LOVELESH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LOVELESH & CO | FY 2020 | 036648N |
Shareholding
The shareholding of Vixen Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Vixen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vixen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vixen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vixen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vixen Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Naveen was appointed as Director on 11 Aug 2017.
Frequently asked questions
Vixen Pharmaceuticals is an active private limited company based in Kaithal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2017 (9+ years old) and is registered under CIN U74999HR2017PTC070308.
The latest financial statements of Vixen Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 12 August 2020. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Vixen Pharmaceuticals is U74999HR2017PTC070308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vixen Pharmaceuticals was incorporated on 11 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Naveen was appointed as Director on 11 Aug 2017. Ravi was appointed as Director on 11 Aug 2017.
The registered office of Vixen Pharmaceuticals is at H.No – 16313 Friends Colony, Kaithal, Haryana, India – 136027.
Vixen Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Vixen Pharmaceuticals is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.
Vixen Pharmaceuticals can be reached at its registered office: H.No – 16313 Friends Colony, Kaithal, Haryana, India – 136027.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
